Table 4.
Hierarchical Structural Regression Models that Estimate Unique Contribution of Co-occurring Symptoms on the Cancer-Related Cognitive Impairment Latent Variable for Either Social Determinants of Health, Patient Specific Factors, or Treatment Factors
| Exogenous Latent Variables | Models | Path coefficient | Z-statistic | p-value | Model R2 | Change in R2* | 95% Confidence interval |
|---|---|---|---|---|---|---|---|
| Pairwise comparison model testing for social determinants of health | |||||||
|
| |||||||
| SDOHa | Model 1 | 0.863 | 8.27 | < .001 | 0.427 | n/a | 0.66, 1.07 |
| SDOH CoOccSymb |
Model 2 | 0.443 −0.951 |
3.37 −9.11 |
.001 < .001 |
0.630 | 0.203 | 0.19, 0.70 −1.16, −0.75 |
|
| |||||||
| Pairwise comparison model testing for patient-specific factors | |||||||
|
| |||||||
| PtSpecFxc | Model 1 | −0.873 | −19.50 | < .001 | 0.433 | n/a | −0.96, −0.79 |
| PtSpecFx CoOccSym |
Model 2 | 0.611 −1.729 |
1.92 −4.92 |
.055 < .001 |
0.577 | 0.144 | −0.01, 1.23 −2.42, −1.04 |
|
| |||||||
| Pairwise comparison model testing for treatment factors | |||||||
|
| |||||||
| TxFxd | Model 1 | 0.092 | 2.20 | .028 | 0.008 | n/a | 0.01, 0.17 |
| TxFx CoOccSym |
Model 2 | −0.059 −1.189 |
−1.18 −18.23 |
.237 < .001 |
0.582 | .574 | −0.16, 0.04 −1.32, −1.06 |
Note. CFI = Comparative fit index; CoOccSym = co-occurring symptoms; PtSpecFx = patient specific factors; RMSEA = root mean squared of approximation; SDOH = social determinants of health; SRM = structural regression model; TxFx = treatment factors.
Change in R2 between SRM of latent variable and outcome variable versus SRM of latent variable, outcome variable, and co-occurring symptoms
Indicator variables for social determinants of health included: years of education, annual income, cumulative lifetime stress, resilience levels
Indicator variables for co-occurring symptoms included: morning and evening fatigue, state anxiety, depressive symptoms, sleep disturbance, occurrence of pain
Indicator variables for patient-specific factors included: age, functional status, comorbidity burden, the personality domain of neuroticism, perceived stress, cancer-specific stress
Indicator variables for treatment factors included: white blood cell count, hemoglobin level, a rating of the toxicity of the chemotherapy regimen, number and type(s) of medications in the antiemetic regimen, chemotherapy cycle length